Organigram Global Inc.

NASDAQ:OGI

Drug Manufacturers - Specialty & Generic

Healthcare
$0.68 -1.74%

-$0.02 today

Market cap
$95.40M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $0.97High $2.24

Volume 0.62M

Average 0.67M

OGI Other Non-Cash Items

Other non-cash adjustments that reconcile net income to operating cash flow.

Organigram Global Inc.NASDAQ: OGI

Other Non-Cash Items · Q2 FY2026 · quarter ended Mar 2026

Other non-cash items dips below year-ago levels

Q2 FY2026 other non-cash items of CA$10.62M (cash outflow) fell 78.7% year over year, behind the +132.4% change in trailing-twelve-month other non-cash items. Sequentially, it fell 56.5% from the prior quarter.

Context

  • Other non-cash items amounted to 7.6% of revenue in FY2025, down 1.8 pp from a year earlier.
  • Other non-cash items increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -78.7% toward the trailing-twelve-month pace of +132.4%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-CA$10.62M-56.5% QoQ
Last fiscal yearSep 2025
CA$14.16M-6.2% YoY
LTMMar 2026
CA$14.1M+132.4% YoY
Other Non-Cash Items past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-78.7%——
1 year-6.2%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Non-Cash Items history

CAD · from the cash flow

Latest · FY2025
14.16M CAD
Year-over-year change
-6.2%
4-year CAGR
+106.7%

Other Non-Cash Items vs competitors

How OGI compares with its peers on the latest reported figures

  • Peers report in different currencies, so other non-cash items is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +132.4% is the 5th highest of 8, against a peer median of +170.6%.
  • Other non-cash items amounts to 5.1% of revenue for OGI, versus a peer median of 9.3%.
OGI Competitors
Other Non-Cash Items for OGI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
IVAInventiva S.A.FY2025€205.07M EUR+121.4%+245.4%4574.3%
HSDTSolana CompanyLTM Mar 2026$109.56M USD+9602.3%+165.2%1142.6%
RNACCartesian Therapeutics, Inc.LTM Mar 2026$76.06M USD+1731.8%+197.2%4285.0%
LFCRLifecore Biomedical, Inc.LTM Mar 2026$34.41M USD—-33.1%25.5%
ACBAurora Cannabis Inc.LTM Mar 2026CA$28.82M CAD+170.6%-40.4%9.3%
OGIOrganigram Global Inc.LTM Mar 2026CA$14.1M CAD+132.4%—5.1%
DERMJourney Medical CorporationLTM Mar 2026$3.64M USD+5017.6%—5.6%
INFUInfuSystem Holdings, Inc.LTM Mar 2026$1.15M USD-137.6%+203.2%0.8%
OBIOOrchestra BioMed Holdings, Inc.LTM Mar 2026$969K USD-33.9%+16.7%3.0%
ELMDElectromed, Inc.LTM Mar 2026$302K USD——0.4%
Peer median (excluding OGI) —+170.6%+165.2%9.3%

Competitors are the stored peer set for OGI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Net Income(130.7M)(14.28M)(229.48M)(45.44M)(24.76M)
Depreciation & Amortization31.03M24.91M24.08M12.08M17.98M
Deferred Income Tax42.21M(88K)(2.66M)0(13.77M)
Stock-Based Compensation3.9M5.13M5.29M7.18M4.22M
Change in Working Capital24.2M(22.88M)12.51M14.96M(2.12M)
Accounts Receivables(6.01M)(24.02M)12.51M(12.06M)(15.29M)
Inventory28.68M(12.22M)000
Accounts Payables2.06M12.15M000
Other Working Capital(542K)1.21M(4.06M)27.02M13.16M
Other Non-Cash Items776K(29M)151.8M15.09M14.16M
Operating Cash Flow(28.59M)(36.21M)(35.8M)3.87M(4.3M)
Capital Expenditures(12.33M)(48.78M)(26.9M)(5.34M)(12.22M)
Acquisitions (Net)(2.54M)(11.06M)00(65.62M)
Purchases of Investments(120.02M)(15M)(7.36M)(29.24M)(1.01M)
Sales of Investments50.85M114.59M36.37M3.52M2.5M
Other Investing Activities(31.08M)4.29M31.46M(8.32M)21.8M
Investing Cash Flow(115.11M)44.03M4.56M(38.77M)(59.35M)
Debt Repayment(116.4M)(1.01M)(64.04K)(786K)(43.08K)
Common Stock Issued284.88M6.34M20K108.56M29.57M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities5.99M6.34M(754.15K)6K(1.29M)
Financing Cash Flow174.46M5.33M(754.15K)107.78M28.24M
Effect of Forex Changes0000(2.57M)
Net Change in Cash30.77M13.15M(68.52M)72.88M(37.98M)
Free Cash Flow(40.92M)(84.99M)(62.7M)(1.47M)(16.52M)

Organigram Global Inc.

NASDAQ:OGI

Intrinsic Alpha fair value

Locked

Current Price

$0.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.